期刊文献+

呼吸病区抗菌药物使用量与铜绿假单孢菌耐药的相关性分析 被引量:3

Analysis of the correlation between Consumption of anti-bacterial agents and resistance rate of Pseudomonas aeruginosa in respiratory unit
下载PDF
导出
摘要 目的 探讨2004~2006年呼吸病区抗茵药物使用与铜绿假单孢茵(PA)耐药水平变化之问的关系。方法计算12种抗茵药物平均每日每百张床位所消耗的DDDs及同期PA的耐药率,并对抗茵药物用量与耐药率进行相关性分析。结果FEP、CFS、MEM的使用量分别与PV对CIP、LEV、CTX的耐药率呈显著相关性;而LEv的使用量又分别与PV对CFS和IPM的耐药率呈显著相关性。结论呼吸病区FEP、CFS、MEM、LEV的使用量与PA耐药率呈显著相关性。 OBJECTIVE To investigate the relationship between administration of anti-bacterial agents and resistance rate of P. aeruginosa in respiratory unit. METHODS The total antibacterial consumption expressed as defined daily doses (DDD)/ day/100bed, as well as resistance rate of P. aeruginosa were collected, and their correlation was analyzed. RESULTS The analysis revealed a significant positive correlation between the consumption of Cefepime and Cefoperazone-Sulbactam and Meropenem between resistance rate of P. aeruginosa of Ciprofloxacin and Levofloxacin and Cefiazidime, respectively. The analysis revealed a significant positive correlation between the consumption of Levofloxacin between resistance rate of P. aeruginosa of Cefoperazone Sulbactam and Imipenem. CONCLUSION The correlation between the consumption of anti-bacterial agents and resistance rate of Pseudomonas aeruginosa revealed an association in respiratory unit.
出处 《海峡药学》 2007年第6期108-110,共3页 Strait Pharmaceutical Journal
基金 广州市卫生局基金资助(2006-YB-158)
关键词 铜绿假单孢茵 耐药性 抗茵药物用量 Pseudomonas aeruginosa Drug resistance Consumption of anti-bacterial agents
  • 相关文献

参考文献5

  • 1National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial disk susceptibili tytests[S].6th ed,Appr ovedstandardM2 A6(M100 S7.Wayne:NCCLS.2003.
  • 2utta M et,al.Antibiotic Consumption,Bacterial Resitance and their Correlation in a Swiss University Hospital and its Adult ICU,Scand[J].J Infect Dis.2003,35:843 ~ 850.
  • 3Mutnick All,Rhomberg PR,Sader HS,et,al.Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America(1999 ~ 2001)[J].Journal of Antimicrobial Chemotherapy,2004,53:290 ~296.
  • 4谢景超.多重耐药铜绿假单胞菌医院暴发流行的动向与监控[J].中国感染控制杂志,2006,5(4):376-379. 被引量:7
  • 5Karlowsky J A,Jone ME,Thornberry C,et al.Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa:data from a multicenter intensive care unit surveillance study(ISS) in the United States[J].J Chemother,2004,16 (5):437 ~ 441.

二级参考文献30

  • 1瞿洪平,闵东,汤耀卿,倪语星.外科监护病房非发酵菌及其耐药性分析[J].中国抗感染化疗杂志,2004,4(4):248-250. 被引量:6
  • 2王杰,周建英,俞云松.铜绿假单胞菌耐药性与产β内酰胺酶的关系[J].中华结核和呼吸杂志,2005,28(4):258-262. 被引量:22
  • 3Goosens H.Susceptibility of multi-drug-resistant Pseudomonas areuginosa in intensive care units:results from European MYSTIC study group[J].Clin Microbiol Infect,2003,9:980-983.
  • 4Falagas M E,Bliziotis I A,Kasiakou S K,et al.Outcome of infections due to pandrug-resistant (PDR) Gran-negative bacteria[J].BMC Inlect Dis; 2005,5(1):24.
  • 5Livermore D M.Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa:Our worst nightmare?[J].Clin Infet Dis,2002,34:634-640.
  • 6Mendes R E,Toleman M A,Ribeiro J.et al:Integron carrying a novel metallo-beta-lactamase gene,blaIMP-16 and a fused form of aminoglycosidc-resistant gene aac(6)-30/aac(6)-Ib:report from the SENTRY Amtimicrobial Surveillance Program[J].Antimicrob Agents Chemother; 2004,48(12):4693-4702.
  • 7Deplano A,Denis Q,Poirel L,et al.Molecular characterization of an epidemic clone of panantibiotic resistant Pseudomonas aeruginosa[J].J Clin Microbiol,2005,43(3):1198-1204.
  • 8Linares J F,Lopez J A,Camafeita E,et al.Overexpression of the multidrug efflux pumps Mex CD-Opr J and Mex EF-OprN is associated with a reduction of type Ⅲ secretion in Pseuddomonss aeruginosa[J].J Bacteriol,2005,187 (4):1384-1391.
  • 9Shan P S,Cannon J P,Sullivan C L,et al.Controlling antimicrobial use and decreasing microbiological laboratory tests for urinary tract infections in Spinal-cord-injury patients with chronic indwelling catheters[J].Am J Health Syst Pharm,2005,62(1):74-77.
  • 10Karlowsky J A,Jones M E,Thornberry C,et al.Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from 2001-2003 tracking resistance in the United States today susveillance studies[J].Clin Infect Dis,2005,40(Suppl 2):S89-98.

共引文献6

同被引文献30

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部